Table 4.
Imaging and laboratory findings of patients upon admission.
| Characteristics | Patients (n = 380) |
|---|---|
| Chest CT findings on admission | |
| Normal | 294 (77.4) |
| Local patchy shadowing | 56 (14.7) |
| Bilateral patchy shadowing | 23 (6.1) |
| Multiple mottling and ground-glass opacity | 7 (1.8) |
| Laboratory findings on admission | |
| White-cell count | |
| Median—per mm3 | 4925 (4053–6245) |
| >10,000 per mm3 | 3 (7.9) |
| <4,000 per mm3 | 89 (23.4) |
| Lymphocyte count | |
| Median—per mm3 | 1895 (1490–2395) |
| <800 per mm3 | 5 (1.3) |
| C-reactive protein | |
| Median—mg/L | 1.9 (0.7–4.7) |
| ≥10 mg/L | 30 (7.9) |
| Procalcitonin | |
| <0.05 ng/ml | 367 (96.6) |
| ≥0.5 ng/ml | 0 (0) |
| Lactate dehydrogenase | |
| Median—U/L | 157.0 (139.8–179.0) |
| ≥250 U/L | 4/342 (1.2) |
| D-dimer | |
| Median—mg/L | 0.04 (0.02–0.09) |
| ≥0.5 mg/L | 7/379 (0.2) |
| Platelet count | |
| Median—per mm3 | 205000 (173250–241500) |
| <100,000 per mm3 | 0 (0) |
| Hemoglobin—g/dl | 14.2 (13.1–15.9) |
| Alanine aminotransferase | |
| Median—U/L | 16.5 (12.0–26.0) |
| >40 U/L | 44 (11.6) |
| Total bilirubin | |
| Median—μmol/L | 11.1 (8.4–12.8) |
| >17.1 μmol/L | 55 (14.5) |
| Creatine kinase ≥ 200 U/L | |
| Median—U/L | 86.0 (64.0–117.0) |
| ≥200 U/L | 21/342 (6.1) |
| Creatinine | |
| Median—μmol/L | 69 (62.0–79.0) |
| ≥133 μmol/L | 0 (0) |
Data are presented as the median (interquartile range), n (%), or n/N (%), where N is the total number of patients with available data. CT denotes computerized tomography.